These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 17627616)
1. Gene transfer of endostatin enhances the efficacy of doxorubicin to suppress human hepatocellular carcinomas in mice. Liu F; Tan G; Li J; Dong X; Krissansen GW; Sun X Cancer Sci; 2007 Sep; 98(9):1381-7. PubMed ID: 17627616 [TBL] [Abstract][Full Text] [Related]
2. Antisense hypoxia-inducible factor 1alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma. Liu F; Wang P; Jiang X; Tan G; Qiao H; Jiang H; Krissansen GW; Sun X Cancer Sci; 2008 Oct; 99(10):2055-61. PubMed ID: 19016766 [TBL] [Abstract][Full Text] [Related]
3. [Gene transfection of endostatin synergizes with doxorubicin to suppress human hepatocellular carcinomas: experiment with mice]. Liu FJ; Tan G; Li J; Sun XY Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2147-51. PubMed ID: 19080480 [TBL] [Abstract][Full Text] [Related]
4. Endostatin gene therapy enhances the efficacy of paclitaxel to suppress breast cancers and metastases in mice. Li J; Dong X; Xu Z; Jiang X; Jiang H; Krissansen GW; Sun X J Biomed Sci; 2008 Jan; 15(1):99-109. PubMed ID: 17705027 [TBL] [Abstract][Full Text] [Related]
5. [Nanoparticle-mediated endostatin gene therapy targeting hepatocellular carcinoma utilizing heat-inducible promoter]. Zhou JJ; Chen RF; Li ZH; Zhou QB; Tang QB; He XY; Lu HW; Guo N Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):795-9. PubMed ID: 19595115 [TBL] [Abstract][Full Text] [Related]
6. Combined endostatin and TRAIL gene transfer suppresses human hepatocellular carcinoma growth and angiogenesis in nude mice. Zhang Y; Qu ZH; Cui M; Guo C; Zhang XM; Ma CH; Sun WS Cancer Biol Ther; 2009 Mar; 8(5):466-73. PubMed ID: 19223770 [TBL] [Abstract][Full Text] [Related]
7. Endostatin gene therapy for liver cancer by a recombinant adenovirus delivery. Li L; Huang JL; Liu QC; Wu PH; Liu RY; Zeng YX; Huang WL World J Gastroenterol; 2004 Jul; 10(13):1867-71. PubMed ID: 15222025 [TBL] [Abstract][Full Text] [Related]
8. Recombinant human endostatin combined with radiotherapy inhibits colorectal cancer growth. Zhang K; Wang Y; Yu X; Shi Y; Yao Y; Wei X; Ma X BMC Cancer; 2017 Dec; 17(1):899. PubMed ID: 29282026 [TBL] [Abstract][Full Text] [Related]
9. Endostar, a modified recombinant human endostatin, exhibits synergistic effects with dexamethasone on angiogenesis and hepatoma growth. Li XQ; Shang BY; Wang DC; Zhang SH; Wu SY; Zhen YS Cancer Lett; 2011 Feb; 301(2):212-20. PubMed ID: 21216091 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor growth in xenografted nude mice with adenovirus-mediated endostatin gene comparison with recombinant endostatin protein. Liang ZH; Wu PH; Li L; Xue G; Zeng YX; Huang WL Chin Med J (Engl); 2004 Dec; 117(12):1809-14. PubMed ID: 15603709 [TBL] [Abstract][Full Text] [Related]
11. Downregulating hypoxia-inducible factor-2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma. He C; Sun XP; Qiao H; Jiang X; Wang D; Jin X; Dong X; Wang J; Jiang H; Sun X Cancer Sci; 2012 Mar; 103(3):528-34. PubMed ID: 22145922 [TBL] [Abstract][Full Text] [Related]
12. Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas. Ding I; Sun JZ; Fenton B; Liu WM; Kimsely P; Okunieff P; Min W Cancer Res; 2001 Jan; 61(2):526-31. PubMed ID: 11212245 [TBL] [Abstract][Full Text] [Related]
13. Sp1 inhibition-mediated upregulation of VEGF 165 b induced by rh-endostatin enhances antiangiogenic and anticancer effect of rh-endostatin in A549. Li ZY; Zhu F; Hu JL; Peng G; Chen J; Zhang S; Chen X; Zhang RG; Chen LJ; Liu P; Luo M; Sun ZH; Ren JH; Huang LL; Wu G Tumour Biol; 2011 Aug; 32(4):677-87. PubMed ID: 21442281 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of von Hippel-Lindau protein synergizes with doxorubicin to suppress hepatocellular carcinoma in mice. Wang J; Ma Y; Jiang H; Zhu H; Liu L; Sun B; Pan S; Krissansen GW; Sun X J Hepatol; 2011 Aug; 55(2):359-68. PubMed ID: 21168458 [TBL] [Abstract][Full Text] [Related]
15. Combining kallistatin gene therapy and meloxicam to treat hepatocellular carcinoma in mice. Jiang X; Li H; Qiao H; Jiang H; Xu R; Sun X Cancer Sci; 2009 Nov; 100(11):2226-33. PubMed ID: 19709125 [TBL] [Abstract][Full Text] [Related]
16. Enhanced antiangiogenic therapy of squamous cell carcinoma by combined endostatin and epidermal growth factor receptor-antisense therapy. Li M; Ye C; Feng C; Riedel F; Liu X; Zeng Q; Grandis JR Clin Cancer Res; 2002 Nov; 8(11):3570-8. PubMed ID: 12429648 [TBL] [Abstract][Full Text] [Related]
17. Conjugation of gold nanoparticles and recombinant human endostatin modulates vascular normalization via interruption of anterior gradient 2-mediated angiogenesis. Pan F; Yang W; Li W; Yang XY; Liu S; Li X; Zhao X; Ding H; Qin L; Pan Y Tumour Biol; 2017 Jul; 39(7):1010428317708547. PubMed ID: 28714365 [TBL] [Abstract][Full Text] [Related]
18. [Human endostatin antiangiogenic gene therapy mediated by recombinant adeno-associated virus vector in nude mouse with endometriosis]. Sun JJ; Yin LR; Mi RR; Ma HD; Guo SJ; Shi Y; Gu YJ Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):45-50. PubMed ID: 20367926 [TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of Stat3-siRNA and endostatin combined therapies, delivered by attenuated Salmonella, on orthotopically implanted hepatocarcinoma. Jia H; Li Y; Zhao T; Li X; Hu J; Yin D; Guo B; Kopecko DJ; Zhao X; Zhang L; Xu DQ Cancer Immunol Immunother; 2012 Nov; 61(11):1977-87. PubMed ID: 22527247 [TBL] [Abstract][Full Text] [Related]
20. Synergistic anti-tumor effect of recombinant human endostatin adenovirus combined with gemcitabine. Wu Y; Yang L; Hu B; Liu JY; Su JM; Luo Y; Ding ZY; Niu T; Li Q; Xie XJ; Wen YJ; Tian L; Kan B; Mao YQ; Wei YQ Anticancer Drugs; 2005 Jun; 16(5):551-7. PubMed ID: 15846121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]